{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T02:36:08Z","timestamp":1776479768754,"version":"3.51.2"},"reference-count":186,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2001,6,1]],"date-time":"2001-06-01T00:00:00Z","timestamp":991353600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2001,6,1]],"date-time":"2001-06-01T00:00:00Z","timestamp":991353600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2001,6]]},"DOI":"10.1067\/mjd.2001.112325","type":"journal-article","created":{"date-parts":[[2002,7,25]],"date-time":"2002-07-25T00:21:43Z","timestamp":1027556503000},"page":"1010-1024","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":63,"title":["High-dose intravenous immunoglobulins: An approach to treat severe immune-mediated and autoimmune diseases of the skin"],"prefix":"10.1067","volume":"44","author":[{"given":"Anita","family":"R\u00fctter","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas A.","family":"Luger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1067\/mjd.2001.112325_bib1","first-page":"43","volume":"60","year":"1982","journal-title":"Bull World Health Organ"},{"key":"10.1067\/mjd.2001.112325_bib2","first-page":"1","year":"1992"},{"key":"10.1067\/mjd.2001.112325_bib3","first-page":"140","article-title":"Clinical uses of intravenous immunoglobulin","volume":"25","author":"Berkmann","year":"1988","journal-title":"Semin Hematol"},{"issue":"Suppl 1","key":"10.1067\/mjd.2001.112325_bib4","first-page":"1","article-title":"Intravenous immunoglobulin: a review","author":"Eibl","year":"1989","journal-title":"Immunodefic Rev"},{"key":"10.1067\/mjd.2001.112325_bib5","year":"1986"},{"key":"10.1067\/mjd.2001.112325_bib6","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/j.1365-2257.1995.tb00322.x","article-title":"Randomized trial of intravenous immunoglobulin prophylaxis for patients with chronic lymphocytic leukaemia and secondary hypogammaglobulinenaemia","volume":"17","author":"Boughton","year":"1995","journal-title":"Clin Lab Haematol"},{"key":"10.1067\/mjd.2001.112325_bib7","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/j.1600-065X.1994.tb00856.x","article-title":"Systemic and topical immunoglobulin treatment in immunocompromised patients","volume":"139","author":"Hammarstrom","year":"1994","journal-title":"Immunol Rev"},{"key":"10.1067\/mjd.2001.112325_bib8","first-page":"37","article-title":"[Use of high-dose intravenous immunoglobulins in pediatric hematology]","volume":"16","author":"Massolo","year":"1994","journal-title":"Pediatr Med Chir"},{"issue":"Suppl 2","key":"10.1067\/mjd.2001.112325_bib9","doi-asserted-by":"crossref","first-page":"S372","DOI":"10.1093\/clinids\/17.Supplement_2.S372","article-title":"Prevention of infection in patients with B cell defects: focus on intravenous immunoglobulin","volume":"17","author":"Yap","year":"1993","journal-title":"Clin Infect Dis"},{"key":"10.1067\/mjd.2001.112325_bib10","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1007\/BF01641421","article-title":"Efficacy of intravenous immunoglobulins in patients with advanced HIV-1 infection: a randomized clinical study","volume":"18","author":"Brunkhorst","year":"1990","journal-title":"Infection"},{"key":"10.1067\/mjd.2001.112325_bib11","doi-asserted-by":"crossref","first-page":"447","DOI":"10.3109\/08923979109019716","article-title":"Clinical and immunologic effects of combination therapy with intravenous immunoglobulins and AZT in HIV-infected patients","volume":"13","author":"De Simone","year":"1991","journal-title":"Immunopharmacol Immunotoxicol"},{"key":"10.1067\/mjd.2001.112325_bib12","first-page":"157","article-title":"Therapy with immunoglobulin of the HIV infection related idiopathic thrombocytopenia","volume":"19","author":"Drenaggi","year":"1991","journal-title":"Allergol Immunopathol (Madr)"},{"key":"10.1067\/mjd.2001.112325_bib13","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/0140-6736(92)92526-L","article-title":"Beneficial effects of intravenous immunoglobulins in AIDS","volume":"340","author":"Saint-Marc","year":"1992","journal-title":"Lancet"},{"key":"10.1067\/mjd.2001.112325_bib14","first-page":"499","article-title":"Immune globulin therapy in allogeneic bone marrow transplant: a critical review","volume":"13","author":"Guglielmo","year":"1994","journal-title":"Bone Marrow Transplant"},{"issue":"Suppl 1","key":"10.1067\/mjd.2001.112325_bib15","first-page":"43","article-title":"Immunomodulation in allogeneic marrow transplantation: use of intravenous immune globulin to suppress acute graft-versus-host disease","volume":"104","author":"Sullivan","year":"1996","journal-title":"Clin Exp Immunol"},{"key":"10.1067\/mjd.2001.112325_bib16","first-page":"44","article-title":"A controlled trial of long-term administration of intravenous immunoglobulin to prevent late infection and chronic graft-vs-host disease after marrow transplantation: clinical outcome and effect on subsequent immune recovery","volume":"2","author":"Sullivan","year":"1996","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1067\/mjd.2001.112325_bib17","first-page":"518","volume":"48","year":"1999","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1067\/mjd.2001.112325_bib18","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1056\/NEJM199201093260206","article-title":"Manipulating the immune system with immune globulin","volume":"326","author":"Dwyer","year":"1992","journal-title":"N Engl J Med"},{"issue":"Suppl","key":"10.1067\/mjd.2001.112325_bib19","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1136\/jnnp.57.Suppl.6","article-title":"Immunomodulating effects of intravenous immunoglobulin in autoimmune and inflammatory diseases","volume":"57","author":"Kaveri","year":"1994","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1067\/mjd.2001.112325_bib20","first-page":"208","article-title":"Use of immune globulins in the prevention and treatment of infections","volume":"12","author":"Siber","year":"1992","journal-title":"Curr Clin Top Infect Dis"},{"key":"10.1067\/mjd.2001.112325_bib21","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1600-065X.1994.tb00858.x","article-title":"V region-mediated selection of autoreactive repertoires by intravenous immunoglobulin (i.v.Ig)","volume":"139","author":"Kazatchkine","year":"1994","journal-title":"Immunol Rev"},{"key":"10.1067\/mjd.2001.112325_bib22","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1016\/S0140-6736(81)92400-4","article-title":"High-dose intravenous gammaglobulin for idiopathic thrombocytopenic purpura in childhood","volume":"1","author":"Imbach","year":"1981","journal-title":"Lancet"},{"key":"10.1067\/mjd.2001.112325_bib23","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/BF00320269","article-title":"Possible mechanisms of intravenous immunoglobulin treatment in childhood idiopathic thrombocytopenic purpura (ITP)","volume":"46","author":"Imbach","year":"1983","journal-title":"Blut"},{"key":"10.1067\/mjd.2001.112325_bib24","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1002\/hep.1840220143","article-title":"Fc receptors in liver sinusoidal endothelial cells in NZB\/W F1 lupus mice: a histological analysis using soluble immunoglobulin G-immune complexes and a monoclonal antibody","volume":"22","author":"Ahmed","year":"1995","journal-title":"Hepatology"},{"key":"10.1067\/mjd.2001.112325_bib25","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/ajh.2830220304","article-title":"Effect of IgG anti-Rho(D) in adult patients with chronic autoimmune thrombocytopenia","volume":"22","author":"Salama","year":"1986","journal-title":"Am J Hematol"},{"key":"10.1067\/mjd.2001.112325_bib26","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0140-6736(83)90175-7","article-title":"Effect of intravenous immunoglobulin in immune thrombocytopenia","volume":"2","author":"Salama","year":"1983","journal-title":"Lancet"},{"key":"10.1067\/mjd.2001.112325_bib27","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/j.1600-065X.1994.tb00861.x","article-title":"Dimer formation in immunoglobulin preparations and speculations on the mechanism of action of intravenous immune globulin in autoimmune diseases","volume":"139","author":"Tankersley","year":"1994","journal-title":"Immunol Rev"},{"key":"10.1067\/mjd.2001.112325_bib28","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/S0140-6736(84)90701-3","article-title":"Anti-idiotypic suppression of autoantibodies to factor VIII (antihaemophilic factor) by high-dose intravenous gammaglobulin","volume":"2","author":"Sultan","year":"1984","journal-title":"Lancet"},{"key":"10.1067\/mjd.2001.112325_bib29","doi-asserted-by":"crossref","first-page":"4104","DOI":"10.4049\/jimmunol.143.12.4104","article-title":"Antiidiotypes against autoantibodies in pooled normal human polyspecific Ig","volume":"143","author":"Rossi","year":"1989","journal-title":"J Immunol"},{"key":"10.1067\/mjd.2001.112325_bib30","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1172\/JCI117520","article-title":"High-dose intravenous immunoglobulin exerts its beneficial effect in patients with dermatomyositis by blocking endomysial deposition of activated complement fragments","volume":"94","author":"Basta","year":"1994","journal-title":"J Clin Invest"},{"issue":"Suppl 1","key":"10.1067\/mjd.2001.112325_bib31","first-page":"21","article-title":"Modulation of complement-mediated immune damage by intravenous immune globulin","volume":"104","author":"Basta","year":"1996","journal-title":"Clin Exp Immunol"},{"key":"10.1067\/mjd.2001.112325_bib32","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1600-065X.1994.tb00855.x","article-title":"Pooled human IgG modulates cytokine production in lymphocytes and monocytes","volume":"139","author":"Andersson","year":"1994","journal-title":"Immunol Rev"},{"key":"10.1067\/mjd.2001.112325_bib33","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/BF00309234","article-title":"Natural human IgG inhibits the production of tumor necrosis factor-alpha and interleukin-1 alpha through the Fc portion","volume":"23","author":"Horiuchi","year":"1993","journal-title":"Surg Today"},{"key":"10.1067\/mjd.2001.112325_bib34","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1128\/iai.58.5.1384-1390.1990","article-title":"Suppression of tumor necrosis factor alpha production by a human immunoglobulin preparation for intravenous use","volume":"58","author":"Shimozato","year":"1990","journal-title":"Infect Immun"},{"key":"10.1067\/mjd.2001.112325_bib35","first-page":"497","article-title":"Human immunoglobulin preparation for intravenous use induces elevation of cellular cyclic adenosine 3\u2032:5\u2032-monophosphate levels, resulting in suppression of tumour necrosis factor alpha and interleukin-1 production","volume":"72","author":"Shimozato","year":"1991","journal-title":"Immunology"},{"key":"10.1067\/mjd.2001.112325_bib36","first-page":"372","article-title":"Human intravenous immuno-globulin modulates monokine production in vitro","volume":"71","author":"Andersson","year":"1990","journal-title":"Immunology"},{"key":"10.1067\/mjd.2001.112325_bib37","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1006\/cyto.1998.0435","article-title":"Pooled human immunoglobulin inhibits IL-4 but not IFN-gamma or TNF-alpha secretion following in vitro stimulation of mononuclear cells with Staphylococcal superantigen","volume":"11","author":"Campbell","year":"1999","journal-title":"Cytokine"},{"issue":"Suppl 15","key":"10.1067\/mjd.2001.112325_bib38","first-page":"S17","article-title":"Immunomodulatory effect of immunoglobulins","volume":"14","author":"Wolf","year":"1996","journal-title":"Clin Exp Rheumatol"},{"key":"10.1067\/mjd.2001.112325_bib39","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1182\/blood.V78.5.1275.1275","article-title":"Production of interleukin-1 receptor antagonist and interleukin-1 beta by peripheral blood mononuclear cells is differentially regulated","volume":"78","author":"Poutsiaka","year":"1991","journal-title":"Blood"},{"key":"10.1067\/mjd.2001.112325_bib40","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/j.1600-065X.1994.tb00857.x","article-title":"IgG induction of IL-1 receptor antagonist production by human monocytes","volume":"139","author":"Arend","year":"1994","journal-title":"Immunol Rev"},{"key":"10.1067\/mjd.2001.112325_bib41","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/0140-6736(93)90563-V","article-title":"Soluble CD4, CD8, and HLA molecules in commercial immunoglobulin preparations","volume":"341","author":"Blasczyk","year":"1993","journal-title":"Lancet"},{"key":"10.1067\/mjd.2001.112325_bib42","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/0140-6736(93)91784-J","article-title":"Immunologically active proteins in intravenous immunoglobulin","volume":"342","author":"Lam","year":"1993","journal-title":"Lancet"},{"key":"10.1067\/mjd.2001.112325_bib43","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0091-6749(97)70217-3","article-title":"Mechanisms of action of intravenous immune serum globulin in autoimmune and inflammatory diseases","volume":"100","author":"Ballow","year":"1997","journal-title":"J Allergy Clin Immunol"},{"key":"10.1067\/mjd.2001.112325_bib44","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1172\/JCI118488","article-title":"Antibodies to a conserved region of HLA class I molecules, capable of modulating CD8 T cell-mediated function, are present in pooled normal immunoglobulin for therapeutic use","volume":"97","author":"Kaveri","year":"1996","journal-title":"J Clin Invest"},{"key":"10.1067\/mjd.2001.112325_bib45","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/S0140-6736(05)78212-X","article-title":"Intravenous immunoglobulins and transforming growth factor beta","volume":"351","author":"Kekow","year":"1998","journal-title":"Lancet"},{"key":"10.1067\/mjd.2001.112325_bib46","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1126\/science.282.5388.490","article-title":"Inhibition of toxic epidrmal necrolysis by blockade of CD95 with human intravenous immunoglobulin","volume":"282","author":"Viard","year":"1998","journal-title":"Science"},{"key":"10.1067\/mjd.2001.112325_bib47","doi-asserted-by":"crossref","first-page":"254","DOI":"10.2165\/00002018-199309040-00003","article-title":"Adverse effects of intravenous immunoglobulin","volume":"9","author":"Misbah","year":"1993","journal-title":"Drug Saf"},{"key":"10.1067\/mjd.2001.112325_bib48","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1056\/NEJM198602273140907","article-title":"Anaphylactic reactions after gamma globulin administration in patients with hypogammaglobulinemia: detection of IgE antibodies to IgA","volume":"314","author":"Burks","year":"1986","journal-title":"N Engl J Med"},{"key":"10.1067\/mjd.2001.112325_bib49","first-page":"134","article-title":"Selective IgA deficiency and systemic lupus erythematosus","volume":"139","author":"Rifle","year":"1988","journal-title":"Ann Med Interne (Paris)"},{"key":"10.1067\/mjd.2001.112325_bib50","doi-asserted-by":"crossref","first-page":"273","DOI":"10.3109\/03009748309098549","article-title":"Persistent and transient IgA deficiency in juvenile rheumatoid arthritis","volume":"12","author":"Pelkonen","year":"1983","journal-title":"Scand J Rheumatol"},{"issue":"Suppl 1","key":"10.1067\/mjd.2001.112325_bib51","first-page":"79","article-title":"Side-effects of intravenous immune globulins","volume":"97","author":"Duhem","year":"1994","journal-title":"Clin Exp Immunol"},{"key":"10.1067\/mjd.2001.112325_bib52","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/0140-6736(92)90806-E","article-title":"Effect of high-dose intravenous immunoglobulin therapy on blood rheology","volume":"339","author":"Reinhart","year":"1992","journal-title":"Lancet"},{"key":"10.1067\/mjd.2001.112325_bib53","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1159\/000169055","article-title":"Acute renal failure following immunoglobulin therapy","volume":"16","author":"Ahsan","year":"1996","journal-title":"Am J Nephrol"},{"key":"10.1067\/mjd.2001.112325_bib54","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1159\/000179925","article-title":"Pinocytosis as the cause of sucrose nephrosis","volume":"8","author":"Schwartz","year":"1971","journal-title":"Nephron"},{"key":"10.1067\/mjd.2001.112325_bib55","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1097\/00005792-199005000-00003","article-title":"Mannitol-induced acute renal failure","volume":"69","author":"Dorman","year":"1990","journal-title":"Medicine (Baltimore)"},{"key":"10.1067\/mjd.2001.112325_bib56","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1001\/archneur.1993.00540020015010","article-title":"Acute renal failure resulting from intravenous immunoglobulin therapy","volume":"50","author":"Tan","year":"1993","journal-title":"Arch Neurol"},{"key":"10.1067\/mjd.2001.112325_bib57","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/0002-9343(87)90110-0","article-title":"Acute cryoglobulinemic renal failure after intravenous infusion of gamma globulin","volume":"82","author":"Barton","year":"1987","journal-title":"Am J Med"},{"key":"10.1067\/mjd.2001.112325_bib58","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/S0022-3476(05)81964-X","article-title":"Immune hemolysis, disseminated intravascular coagulation, and serum sickness after large doses of immune globulin given intravenously for Kawasaki disease","volume":"120","author":"Comenzo","year":"1992","journal-title":"J Pediatr"},{"key":"10.1067\/mjd.2001.112325_bib59","doi-asserted-by":"crossref","first-page":"3789","DOI":"10.1182\/blood.V82.12.3789.3789","article-title":"Hemolysis after high-dose intravenous Ig","volume":"82","author":"Thomas","year":"1993","journal-title":"Blood"},{"key":"10.1067\/mjd.2001.112325_bib60","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1056\/NEJM199008303230917","article-title":"Intravenous immune globulin and acute aseptic meningitis","volume":"323","author":"Casteels-Van Daele","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1067\/mjd.2001.112325_bib61","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1001\/archderm.134.1.80","article-title":"Dermatological uses of high-dose intravenous immunoglobulin","volume":"134","author":"Jolles","year":"1998","journal-title":"Arch Dermatol"},{"key":"10.1067\/mjd.2001.112325_bib62","first-page":"173","article-title":"Lupus nephritis: update on pathogenesis and disease mechanisms","volume":"19","author":"Foster","year":"1999","journal-title":"Semin Nephrol"},{"key":"10.1067\/mjd.2001.112325_bib63","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/1529-0131(199902)42:2<199::AID-ANR1>3.0.CO;2-1","article-title":"Fine specificity of the autoimmune response to the Ro\/SSA and La\/SSB ribonucleoproteins","volume":"42","author":"Scofield","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1067\/mjd.2001.112325_bib64","first-page":"48","article-title":"The role of autoantibodies in the pathogenesis of lupus nephritis","volume":"19","author":"Madaio","year":"1999","journal-title":"Semin Nephrol"},{"key":"10.1067\/mjd.2001.112325_bib65","first-page":"2","article-title":"Natural history and treatment of lupus nephritis","volume":"19","author":"Austin","year":"1999","journal-title":"Semin Nephrol"},{"key":"10.1067\/mjd.2001.112325_bib66","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1056\/NEJM198603063141004","article-title":"Therapy of lupus nephritis: controlled trial of prednisone and cytotoxic drugs","volume":"314","author":"Austin","year":"1986","journal-title":"N Engl J Med"},{"key":"10.1067\/mjd.2001.112325_bib67","first-page":"495","article-title":"Treatment of systemic lupus erythematosus by prolonged administration of high dose intravenous immunoglobulin: report of 2 cases","volume":"20","author":"Winder","year":"1993","journal-title":"J Rheumatol"},{"issue":"Suppl 1","key":"10.1067\/mjd.2001.112325_bib68","first-page":"26","article-title":"[Immunoglobulin therapy for systemic lupus erythematosus]","volume":"21","author":"Utku","year":"1993","journal-title":"Immun Infekt"},{"key":"10.1067\/mjd.2001.112325_bib69","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1136\/ard.49.11.939","article-title":"Recurrent cerebral infarction and the antiphospholipid syndrome: effect of intravenous gammaglobulin in a patient with systemic lupus erythematosus","volume":"49","author":"Sturfelt","year":"1990","journal-title":"Ann Rheum Dis"},{"key":"10.1067\/mjd.2001.112325_bib70","first-page":"71","article-title":"High dose intravenous immunoglobulins in systemic lupus erythematosus: clinical and serological results of a pilot study","volume":"23","author":"Schroeder","year":"1996","journal-title":"J Rheumatol"},{"issue":"Suppl 1","key":"10.1067\/mjd.2001.112325_bib71","first-page":"131","article-title":"[Intravenous administration of immunoglobulins in systemic lupus erythematosus: review of the literature and initial clinical experiences]","volume":"20","author":"Pirner","year":"1993","journal-title":"Infusionsther Transfusionsmed"},{"key":"10.1067\/mjd.2001.112325_bib72","first-page":"4039","article-title":"[Intravenous immunoglobulin administration to a patient with systemic lupus erythematosus and pneumococcal septicemia]","volume":"156","author":"Maltbaek","year":"1994","journal-title":"Ugeskr Laeger"},{"key":"10.1067\/mjd.2001.112325_bib73","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1159\/000185772","article-title":"Improvement of histological and immunological change in steroid and immunosuppressive drug-resistant lupus nephritis by high-dose intravenous gamma globulin","volume":"53","author":"Lin","year":"1989","journal-title":"Nephron"},{"key":"10.1067\/mjd.2001.112325_bib74","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1002\/art.1780400426","article-title":"Treatment of acquired factor VIII inhibitor using intravenous immunoglobulin in two patients with systemic lupus erythematosus","volume":"40","author":"Lafferty","year":"1997","journal-title":"Arthritis Rheum"},{"key":"10.1067\/mjd.2001.112325_bib75","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1177\/106002809703100218","article-title":"Intravenous immune globulin for inducing remissions in systemic lupus erythematosus","volume":"31","author":"Heyneman","year":"1997","journal-title":"Ann Pharmacother"},{"key":"10.1067\/mjd.2001.112325_bib76","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1136\/jnnp.55.1.84","article-title":"Treatment of a case with pooled intravenous immunoglobulin as an alternative to immunosuppression","volume":"55","author":"Hall","year":"1992","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1067\/mjd.2001.112325_bib77","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/BF00319968","article-title":"IgG therapy in systemic lupus erythematosus: two case reports","volume":"48","author":"Gaedicke","year":"1984","journal-title":"Blut"},{"key":"10.1067\/mjd.2001.112325_bib78","first-page":"1635","article-title":"Lupus refractory pleural effusion: transient response to intravenous immunoglobulins","volume":"18","author":"Ben Chetrit","year":"1991","journal-title":"J Rheumatol"},{"key":"10.1067\/mjd.2001.112325_bib79","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1681\/ASN.V5101746","article-title":"Intravenous immune globulin in the treatment of patients with systemic lupus erythematosus and end-stage renal disease","volume":"5","author":"Becker","year":"1995","journal-title":"J Am Soc Nephrol"},{"key":"10.1067\/mjd.2001.112325_bib80","first-page":"375","article-title":"Successful treatment of refractory systemic lupus erythematosus with intravenous immunoglobulins","volume":"17","author":"Akashi","year":"1990","journal-title":"J Rheumatol"},{"key":"10.1067\/mjd.2001.112325_bib81","first-page":"163","article-title":"Long-term i.v. Ig treatment in systemic lupus erythematosus","volume":"12","author":"Francioni","year":"1994","journal-title":"Clin Exp Rheumatol"},{"key":"10.1067\/mjd.2001.112325_bib82","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/S0140-6736(99)01575-5","article-title":"Intravenous immunoglobulin compared with cyclophosphamide for proliferative lupus nephritis","volume":"354","author":"Boletis","year":"1999","journal-title":"Lancet"},{"key":"10.1067\/mjd.2001.112325_bib83","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1007\/s100670050079","article-title":"Successful treatment of systemic lupus erythematosus cerebritis with intravenous immunoglobulin","volume":"18","author":"Sherer","year":"1999","journal-title":"Clin Rheumatol"},{"key":"10.1067\/mjd.2001.112325_bib84","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1182\/blood.V93.7.2149","article-title":"Antiprothrombin antibodies: detection and clinical significance in the antiphospholipid syndrome","volume":"93","author":"Galli","year":"1999","journal-title":"Blood"},{"key":"10.1067\/mjd.2001.112325_bib85","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1191\/096120398678920451","article-title":"Use of intravenous immunoglobulin therapy in pregnancy in systemic lupus erythematosus and antiphospholipid antibody syndrome","volume":"7","author":"Gordon","year":"1998","journal-title":"Lupus"},{"key":"10.1067\/mjd.2001.112325_bib86","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0301-2115(98)00070-0","article-title":"Intravenous immunoglobulin therapy in compromised pregnancies associated with antiphospholipid antibodies and systemic lupus erythematosus","volume":"79","author":"Somerset","year":"1998","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1067\/mjd.2001.112325_bib87","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1001\/archderm.135.9.1124","article-title":"High-dose intravenous immunoglobulin in cutaneous lupus erythematosus","volume":"135","author":"Genereau","year":"1999","journal-title":"Arch Dermatol"},{"key":"10.1067\/mjd.2001.112325_bib88","first-page":"494","article-title":"Inflammatory myopathies (polymyositis, dermatomyositis, inclusion body myositis)","volume":"24","author":"Bertorini","year":"1998","journal-title":"Compr Ther"},{"key":"10.1067\/mjd.2001.112325_bib89","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/0049-0172(86)90014-4","article-title":"Adult onset polymyositis\/dermatomyositis: an analysis of clinical and laboratory features and survival in 76 patients with a review of the literature","volume":"15","author":"Hochberg","year":"1986","journal-title":"Semin Arthritis Rheum"},{"key":"10.1067\/mjd.2001.112325_bib90","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1056\/NEJM199111213252107","article-title":"Polymyositis, dermatomyositis and inclusion-body myositis","volume":"325","author":"Dalakas","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1067\/mjd.2001.112325_bib91","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1056\/NEJM199312303292704","article-title":"A controlled trial of high-dose intravenous immune globulin infusions as treatment for dermatomyositis","volume":"329","author":"Dalakas","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1067\/mjd.2001.112325_bib92","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/S0190-9622(98)70263-4","article-title":"Dermatomyositis","volume":"39","author":"Kovacs","year":"1998","journal-title":"J Am Acad Dermatol"},{"key":"10.1067\/mjd.2001.112325_bib93","first-page":"664","article-title":"[Immunopathology and treatment of polymyositis and dermatomyositis]","volume":"87","author":"Hase","year":"1998","journal-title":"Nippon Naika Gakkai Zasshi"},{"key":"10.1067\/mjd.2001.112325_bib94","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1177\/088307389801300303","article-title":"Drug therapy in juvenile dermatomyositis: follow-up study","volume":"13","author":"Ng","year":"1998","journal-title":"J Child Neurol"},{"key":"10.1067\/mjd.2001.112325_bib95","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/S0190-9622(98)70562-6","article-title":"The value of methotrexate in dermatomyositis","volume":"38","author":"Zieglschmid-Adams","year":"1998","journal-title":"J Am Acad Dermatol"},{"key":"10.1067\/mjd.2001.112325_bib96","first-page":"139","article-title":"IGIV in neurology: evidence and recommendations","volume":"26","author":"Bril","year":"1999","journal-title":"Can J Neurol Sci"},{"key":"10.1067\/mjd.2001.112325_bib97","first-page":"244","article-title":"[Effectiveness of intravenous immunoglobulins in polymyositis and dermatomyositis: an open trial in 15 patients","volume":"20","author":"Cherin","year":"1991","journal-title":"Presse Med"},{"key":"10.1067\/mjd.2001.112325_bib98","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/j.1365-2133.1994.tb02906.x","article-title":"Juvenile dermatomyositis: treatment iwth intravenous gammaglobulin","volume":"130","author":"Collet","year":"1994","journal-title":"Br J Dermatol"},{"key":"10.1067\/mjd.2001.112325_bib99","doi-asserted-by":"crossref","first-page":"642","DOI":"10.2169\/internalmedicine.37.642","article-title":"High-dose immunoglobulin therapy for a patient with dermatomyositis","volume":"37","author":"Furuya","year":"1998","journal-title":"Intern Med"},{"key":"10.1067\/mjd.2001.112325_bib100","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1136\/jnnp.65.1.107","article-title":"Immunoglobulin therapy in inflammatory myopathies","volume":"65","author":"Mastaglia","year":"1998","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1067\/mjd.2001.112325_bib101","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1111\/j.1365-2230.1995.tb02675.x","article-title":"Dermatomyositis treated with high-dose intravenous immunoglobulins and associated with panniculitis","volume":"20","author":"Sabroe","year":"1995","journal-title":"Clin Exp Dermatol"},{"key":"10.1067\/mjd.2001.112325_bib102","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1007\/s001050050185","article-title":"[High dosage intravenous gamma globulin therapy in juvenile dermatomyositis]","volume":"45","author":"Schmidt","year":"1994","journal-title":"Hautarzt"},{"key":"10.1067\/mjd.2001.112325_bib103","first-page":"89","article-title":"Cutaneous ulcers of refractory adult dermatomyositis responsive to intravenous immunoglobulin","volume":"62","author":"Peake","year":"1998","journal-title":"Cutis"},{"key":"10.1067\/mjd.2001.112325_bib104","first-page":"29","article-title":"High dose intravenous immunoglobulin (IVIG) in dermatomyositis: clinical responses and effect on sIL-2R levels","volume":"10","author":"Gottfried","year":"2000","journal-title":"Eur J Dermatol"},{"key":"10.1067\/mjd.2001.112325_bib105","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S1085-5629(98)80063-1","article-title":"Management of systemic sclerosis: the art and science","volume":"17","author":"Stone","year":"1998","journal-title":"Semin Cutan Med Surg"},{"key":"10.1067\/mjd.2001.112325_bib106","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1468-3083.1998.tb00945.x","article-title":"Pathophysiology of scleroderma: an update","volume":"11","author":"Haustein","year":"1998","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1067\/mjd.2001.112325_bib107","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1111\/j.1365-2133.1990.tb01462.x","article-title":"Efficacy of intravenous immunoglobulins in sclerodermatomyositis","volume":"123","author":"Bodemer","year":"1990","journal-title":"Br J Dermatol"},{"key":"10.1067\/mjd.2001.112325_bib108","first-page":"70","article-title":"Intraven\u00f6se Immunglobuline in der Behandlung von Autoimmunerkrankungen der Haut","author":"R\u00fctter","year":"1997"},{"key":"10.1067\/mjd.2001.112325_bib109","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1046\/j.1365-2230.1998.00378.x","article-title":"Disabling morphoea of childhood: beneficial effect of intravenous immunoglobulin therapy","volume":"23","author":"Wollina","year":"1998","journal-title":"Clin Exp Dermatol"},{"key":"10.1067\/mjd.2001.112325_bib110","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1111\/1523-1747.ep12606050","article-title":"A case of pemphigus vulgaris showing reactivity with pemphigus antigens (Dsg1 and Dsg3) and desmocollins","volume":"104","author":"Hashimoto","year":"1995","journal-title":"J Invest Dermatol"},{"issue":"Suppl 2","key":"10.1067\/mjd.2001.112325_bib111","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1159\/000246985","article-title":"Pemphigus: past, present and future","volume":"189","author":"Thivolet","year":"1994","journal-title":"Dermatology"},{"key":"10.1067\/mjd.2001.112325_bib112","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1111\/1523-1747.ep12613668","article-title":"Adhesion molecules. I: Keratinocyte-keratinocyte interactions: cadherins and pemphigus","volume":"104","author":"Amagai","year":"1995","journal-title":"J Invest Dermatol"},{"key":"10.1067\/mjd.2001.112325_bib113","first-page":"63","article-title":"Immunofluorescence and immunoblot studies on the reactivity of pemphigus vulgaris and pemphigus foliaceus sera with desmoglein 3 and desmoglein 1","volume":"4","author":"Hashimoto","year":"1995","journal-title":"Epithelial Cell Biol"},{"key":"10.1067\/mjd.2001.112325_bib114","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/S0190-9622(99)70145-3","article-title":"The new pemphigus variants","volume":"40","author":"Robinson","year":"1999","journal-title":"J Am Acad Dermatol"},{"key":"10.1067\/mjd.2001.112325_bib115","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1001\/archderm.1976.01630310024005","article-title":"Pemphigus: a 20-year review of 107 patients treated with corticosteroids","volume":"112","author":"Rosenberg","year":"1976","journal-title":"Arch Dermatol"},{"key":"10.1067\/mjd.2001.112325_bib116","doi-asserted-by":"crossref","first-page":"964","DOI":"10.7326\/0003-4819-103-6-965_1","article-title":"Bullous pemphigoid and intravenous gammaglobulin","volume":"103","author":"Godard","year":"1985","journal-title":"Ann Intern Med"},{"key":"10.1067\/mjd.2001.112325_bib117","first-page":"275","article-title":"Intraven\u00f6se Immunglobuline, ein wirksames und gut vertr\u00e4gliches Additivum in der Behandlung therapieresistenter Autoimmundermatosen","author":"R\u00fctter","year":"1994"},{"key":"10.1067\/mjd.2001.112325_bib118","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.1365-2133.1995.tb02631.x","article-title":"Adjuvant high-dose intravenous gammaglobulin in the treatment of pemphigus and bullous pemphigoid: experience in six patients","volume":"133","author":"Beckers","year":"1995","journal-title":"Br J Dermatol"},{"key":"10.1067\/mjd.2001.112325_bib119","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1111\/j.1365-2133.1995.tb06952.x","article-title":"High-dose intravenous immunoglobulins for immediate control of severe pemphigus","volume":"133","author":"Messer","year":"1995","journal-title":"Br J Dermatol"},{"key":"10.1067\/mjd.2001.112325_bib120","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/S0190-9622(89)80148-3","article-title":"High-dosage intravenous gamma globulin: therapeutic failure in pemphigus and pemphigoid","volume":"20","author":"Tappeiner","year":"1989","journal-title":"J Am Acad Dermatol"},{"key":"10.1067\/mjd.2001.112325_bib121","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1046\/j.1365-2133.1999.03071.x","article-title":"Successful treatment of recalcitrant penicillamine-induced pemphigus foliaceus by low-dose intravenous immunoglobulins","volume":"141","author":"Toth","year":"1999","journal-title":"Br J Dermatol"},{"key":"10.1067\/mjd.2001.112325_bib122","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1007\/s001050050824","article-title":"[Adjuvant therapy of pemphigus vulgaris and pemphigus foliaceus with intravenous immunoglobulins]","volume":"49","author":"Enk","year":"1998","journal-title":"Hautarzt"},{"key":"10.1067\/mjd.2001.112325_bib123","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1046\/j.1365-2133.1999.02817.x","article-title":"High-dose intravenous immune globulin for the treatment of autoimmune blistering diseases: an evaluation of its use in 14 cases","volume":"140","author":"Harman","year":"1999","journal-title":"Br J Dermatol"},{"key":"10.1067\/mjd.2001.112325_bib124","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1046\/j.1365-2133.1996.d01-949.x","article-title":"Successful treatment of pemphigus vulgaris by pulsed intravenous immunoglobulin therapy","volume":"135","author":"Bewley","year":"1996","journal-title":"Br J Dermatol"},{"key":"10.1067\/mjd.2001.112325_bib125","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1046\/j.1365-2133.1998.02297.x","article-title":"Intravenous immunoglobulins for pemphigus vulgaris: adjuvant or first choice therapy?","volume":"138","author":"Colonna","year":"1998","journal-title":"Br J Dermatol"},{"key":"10.1067\/mjd.2001.112325_bib126","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/S0190-9622(08)80783-9","article-title":"Effects of intravenous gamma-globulin in pemphigus","volume":"22","author":"Humbert","year":"1990","journal-title":"J Am Acad Dermatol"},{"key":"10.1067\/mjd.2001.112325_bib127","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1111\/j.1365-2133.1996.tb03913.x","article-title":"Successful treatment of refractory mucosal lesions of pemphigus vulgaris using intravenous gammaglobulin as adjuvant therapy","volume":"135","author":"Wever","year":"1996","journal-title":"Br J Dermatol"},{"key":"10.1067\/mjd.2001.112325_bib128","first-page":"595","article-title":"conversion of pemphigoid gestationis to bullous pemphigoid: two refractory cases highlighting this association","volume":"135","author":"Jenkins","year":"1996","journal-title":"Br J Dermatol"},{"key":"10.1067\/mjd.2001.112325_bib129","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1001\/archderm.1985.01660070114031","article-title":"Herpes gestationis: persistent disease activity 11 years post partum","volume":"121","author":"Fine","year":"1985","journal-title":"Arch Dermatol"},{"key":"10.1067\/mjd.2001.112325_bib130","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1046\/j.1365-2230.1998.00342.x","article-title":"A severe persistent case of pemphigoid gestationis treated with intravenous immunoglobulins and cyclosporin","volume":"23","author":"Hern","year":"1998","journal-title":"Clin Exp Dermatol"},{"key":"10.1067\/mjd.2001.112325_bib131","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1111\/j.1365-2133.1989.tb01327.x","article-title":"Identification of the epidermolysis bullosa acquisita antigen by LH 7.2 monoclonal antibody: use in diagnosis","volume":"120","author":"Tatnall","year":"1989","journal-title":"Br J Dermatol"},{"key":"10.1067\/mjd.2001.112325_bib132","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1111\/j.1365-2133.1990.tb07278.x","article-title":"Epidermolysis bullosa acquisita antigen and the carboxy terminus of type VII collagen have a common immunolocalization to anchoring fibrils and lamina densa of basement membrane","volume":"122","author":"Shimizu","year":"1990","journal-title":"Br J Dermatol"},{"key":"10.1067\/mjd.2001.112325_bib133","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/0190-9622(93)70189-Z","article-title":"Epidermolysis bullosa acquisita: efficacy of high-dose intravenous immunoglobulins","volume":"29","author":"Meier","year":"1993","journal-title":"J Am Acad Dermatol"},{"key":"10.1067\/mjd.2001.112325_bib134","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1111\/j.1365-2133.1995.tb00735.x","article-title":"Successful treatment of epidermolysis bullosa acquisita using intravenous immunoglobulins","volume":"132","author":"Mohr","year":"1995","journal-title":"Br J Dermatol"},{"key":"10.1067\/mjd.2001.112325_bib135","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0190-9622(97)80411-2","article-title":"Intravenous immunoglobulin treatment in therapy-resistant epidermolysis bullosa acquisita","volume":"36","author":"Kofler","year":"1997","journal-title":"J Am Acad Dermatol"},{"key":"10.1067\/mjd.2001.112325_bib136","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1111\/1523-1747.ep12345793","article-title":"97-kDa linear IgA bullous dermatosis (LAD) antigen localizes to the lamina lucida of the epidermal basement membrane","volume":"106","author":"Ishiko","year":"1996","journal-title":"J Invest Dermatol"},{"key":"10.1067\/mjd.2001.112325_bib137","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1111\/j.1365-2133.1996.tb07624.x","article-title":"A case of linear IgA bullous dermatosis with IgA anti-type VII collagen autoantibodies","volume":"134","author":"Hashimoto","year":"1996","journal-title":"Br J Dermatol"},{"key":"10.1067\/mjd.2001.112325_bib138","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/S0190-9622(99)70504-9","article-title":"Linear IgA bullous dermatosis in a patient with chronic renal failure: response to intravenous immunoglobulin therapy","volume":"40","author":"Khan","year":"1999","journal-title":"J Am Acad Dermatol"},{"key":"10.1067\/mjd.2001.112325_bib139","doi-asserted-by":"crossref","first-page":"28S","DOI":"10.1111\/1523-1747.ep12388434","article-title":"The spectrum of Stevens-Johnson syndrome and toxic epidermal necrolysis: a clinical classification","volume":"102","author":"Roujeau","year":"1994","journal-title":"J Invest Dermatol"},{"key":"10.1067\/mjd.2001.112325_bib140","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1056\/NEJM199411103311906","article-title":"Severe adverse cutaneous reactions to drugs","volume":"331","author":"Roujeau","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1067\/mjd.2001.112325_bib141","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1046\/j.1365-2133.2000.03276.x","article-title":"A case of toxic epidermal necrolysis treated with intravenous immunoglobulin","volume":"142","author":"Magina","year":"2000","journal-title":"Br J Dermatol"},{"key":"10.1067\/mjd.2001.112325_bib142","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1111\/j.1365-2133.1994.tb13111.x","article-title":"Cyclosporin in atopic dermatitis: a multicentre placebo-controlled study","volume":"130","author":"van Joost","year":"1994","journal-title":"Br J Dermatol"},{"key":"10.1067\/mjd.2001.112325_bib143","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1001\/archderm.1996.03890340094015","article-title":"Assembling the puzzle pieces in atopic inflammation","volume":"132","author":"Hanifin","year":"1996","journal-title":"Arch Dermatol"},{"key":"10.1067\/mjd.2001.112325_bib144","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/1523-1747.ep12297888","article-title":"Type 4 phosphodiesterase inhibitors have clinical and in vitro anti-inflammatory effects in atopic dermatitis","volume":"107","author":"Hanifin","year":"1996","journal-title":"J Invest Dermatol"},{"key":"10.1067\/mjd.2001.112325_bib145","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/S0190-9622(97)80284-8","article-title":"Recent developments in the treatment of atopic eczema","volume":"36","author":"Brehler","year":"1997","journal-title":"J Am Acad Dermatol"},{"key":"10.1067\/mjd.2001.112325_bib146","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1136\/adc.70.4.335","article-title":"High dose gammaglobulin treatment for atopic dermatitis","volume":"70","author":"Kimata","year":"1994","journal-title":"Arch Dis Child"},{"issue":"Suppl 1","key":"10.1067\/mjd.2001.112325_bib147","first-page":"61","article-title":"Intravenous immune globulin: an alternative therapy in steroid-dependent allergic diseases","volume":"104","author":"Gelfand","year":"1996","journal-title":"Clin Exp Immunol"},{"key":"10.1067\/mjd.2001.112325_bib148","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0190-9622(99)70544-X","article-title":"Intracellular interleukin-4 profiles during high-dose intravenous immunoglobulin treatment of therapy-resistant atopic dermatitis","volume":"40","author":"Jolles","year":"1999","journal-title":"J Am Acad Dermatol"},{"key":"10.1067\/mjd.2001.112325_bib149","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/S0140-6736(66)90119-X","article-title":"Job's syndrome: recurrent, \u201ccold,\u201d staphylococcal abscesses","volume":"1","author":"Davis","year":"1966","journal-title":"Lancet"},{"key":"10.1067\/mjd.2001.112325_bib150","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/S0140-6736(66)92255-0","article-title":"Hypergammaglobulinaemia, antibody deficiency, autoimmune haemolytic anaemia, and nephritis in an infant with a familial lymphopenic immune defect","volume":"2","author":"Schaller","year":"1966","journal-title":"Lancet"},{"key":"10.1067\/mjd.2001.112325_bib151","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/S0140-6736(89)90759-9","article-title":"Hyper-IgE syndrome and H2-receptor blockade","volume":"2","author":"Thompson","year":"1989","journal-title":"Lancet"},{"key":"10.1067\/mjd.2001.112325_bib152","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1016\/S0140-6736(89)92823-7","article-title":"Alpha-interferon treatment of patient with hyper IgE syndrome","volume":"1","author":"Souillet","year":"1989","journal-title":"Lancet"},{"key":"10.1067\/mjd.2001.112325_bib153","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/S0091-6749(95)70185-0","article-title":"High-dose intravenous gamma-globulin treatment for hyperimmunoglobulinemia E syndrome","volume":"95","author":"Kimata","year":"1995","journal-title":"J Allergy Clin Immunol"},{"key":"10.1067\/mjd.2001.112325_bib154","doi-asserted-by":"crossref","first-page":"6723","DOI":"10.4049\/jimmunol.151.12.6723","article-title":"Nedocromil sodium selectively inhibits IgE and IgG4 production in human B cells stimulated with IL-4","volume":"151","author":"Kimata","year":"1993","journal-title":"J Immunol"},{"key":"10.1067\/mjd.2001.112325_bib155","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/0091-6749(91)90213-8","article-title":"Shifts in interleukin-4 and interferon-gamma production by T cells of patients with elevated serum IgE levels and the modulatory effects of these lymphokines on spontaneous IgE synthesis","volume":"87","author":"Rousset","year":"1991","journal-title":"J Allergy Clin Immunol"},{"key":"10.1067\/mjd.2001.112325_bib156","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1378\/chest.114.5.1349","article-title":"Benefits of high-dose i.v. immunoglobulin in patients with severe steroid-dependent asthma","volume":"114","author":"Landwehr","year":"1998","journal-title":"Chest"},{"key":"10.1067\/mjd.2001.112325_bib157","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0022-3476(88)80137-9","article-title":"Asthma and selective immunoglobulin subclass deficiency: improvement of asthma after immunoglobulin replacement therapy","volume":"112","author":"Page","year":"1988","journal-title":"J Pediatr"},{"key":"10.1067\/mjd.2001.112325_bib158","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/0091-6749(91)90420-S","article-title":"An open-label study of high-dose intravenous immunoglobulin in severe childhood asthma","volume":"87","author":"Mazer","year":"1991","journal-title":"J Allergy Clin Immunol"},{"key":"10.1067\/mjd.2001.112325_bib159","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/S0091-6749(99)70424-0","article-title":"Effect of intravenous immunoglobulin on steroid consumption in patients with severe asthma: a double-blind, placebo-controlled, randomized trial","volume":"103","author":"Salmun","year":"1999","journal-title":"J Allergy Clin Immunol"},{"key":"10.1067\/mjd.2001.112325_bib160","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1111\/1523-1747.ep12338544","article-title":"Dermal mast cell activation by autoantibodies against the high affinity IgE receptor in chronic urticaria","volume":"106","author":"Niimi","year":"1996","journal-title":"J Invest Dermatol"},{"key":"10.1067\/mjd.2001.112325_bib161","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1172\/JCI511","article-title":"Anti-FcepsilonRIalpha autoantibodies in autoimmune-mediated disorders: identification of a structure-function relationship","volume":"101","author":"Fiebiger","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1067\/mjd.2001.112325_bib162","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/S0091-6749(98)70032-6","article-title":"Successful treatment of chronic urticaria with leukotriene antagonists","volume":"102","author":"Ellis","year":"1998","journal-title":"J Allergy Clin Immunol"},{"key":"10.1067\/mjd.2001.112325_bib163","first-page":"49","article-title":"[Chronic urticaria\u2014update]","volume":"134","author":"Kessel","year":"1998","journal-title":"Harefuah"},{"key":"10.1067\/mjd.2001.112325_bib164","first-page":"2170","article-title":"Chronic urticaria","volume":"44","author":"Leznoff","year":"1998","journal-title":"Can Fam Physician"},{"key":"10.1067\/mjd.2001.112325_bib165","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1046\/j.1365-2133.1998.02033.x","article-title":"Intravenous immunoglobulin in autoimmune chronic urticaria","volume":"138","author":"O'Donnell","year":"1998","journal-title":"Br J Dermatol"},{"key":"10.1067\/mjd.2001.112325_bib166","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1016\/0002-9149(82)90256-9","article-title":"Fate of coronary aneurysms in Kawasaki disease: serial coronary angiography and long-term follow-up study","volume":"49","author":"Kato","year":"1982","journal-title":"Am J Cardiol"},{"key":"10.1067\/mjd.2001.112325_bib167","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1002\/1529-0131(199809)41:9<1538::AID-ART3>3.0.CO;2-M","article-title":"The immunopathogenesis and management of Kawasaki syndrome","volume":"41","author":"Leung","year":"1998","journal-title":"Arthritis Rheum"},{"key":"10.1067\/mjd.2001.112325_bib168","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1016\/S0031-3955(16)40059-3","article-title":"Kawasaki disease","volume":"42","author":"Shulman","year":"1995","journal-title":"Pediatr Clin North Am"},{"key":"10.1067\/mjd.2001.112325_bib169","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1128\/CMR.11.3.405","article-title":"Kawasaki syndrome","volume":"11","author":"Rowley","year":"1998","journal-title":"Clin Microbiol Rev"},{"key":"10.1067\/mjd.2001.112325_bib170","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/S0140-6736(84)91504-6","article-title":"High-dose intravenous gammaglobulin for Kawasaki disease","volume":"2","author":"Furusho","year":"1984","journal-title":"Lancet"},{"key":"10.1067\/mjd.2001.112325_bib171","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1056\/NEJM199106063242305","article-title":"A single intravenous infusion of gamma globulin as compared with four infusions in the treatment of acute Kawasaki syndrome","volume":"324","author":"Newburger","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1067\/mjd.2001.112325_bib172","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1056\/NEJM198608073150601","article-title":"The treatment of Kawasaki syndrome with intravenous gamma globulin","volume":"315","author":"Newburger","year":"1986","journal-title":"N Engl J Med"},{"key":"10.1067\/mjd.2001.112325_bib173","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/BF02914373","article-title":"The immunoregulatory effects of IVIg in Kawasaki disease and other autoimmune diseases","volume":"10","author":"Leung","year":"1992","journal-title":"Clin Rev Allergy"},{"key":"10.1067\/mjd.2001.112325_bib174","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1016\/S0140-6736(89)91910-7","article-title":"Endothelial cell activation and high interleukin-1 secretion in the pathogenesis of acute Kawasaki disease","volume":"2","author":"Leung","year":"1989","journal-title":"Lancet"},{"key":"10.1067\/mjd.2001.112325_bib175","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S0190-9622(96)90428-4","article-title":"Pyoderma gangrenosum: classification and management","volume":"34","author":"Powell","year":"1996","journal-title":"J Am Acad Dermatol"},{"key":"10.1067\/mjd.2001.112325_bib176","first-page":"51","article-title":"Pyoderma gangrenosum and related disorders","volume":"4","author":"Callen","year":"1989","journal-title":"Adv Dermatol"},{"key":"10.1067\/mjd.2001.112325_bib177","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/S0190-9622(89)70218-8","article-title":"Chlorambucil: an effective cortico-steroid-sparing therapy for pyoderma gangrenosum","volume":"21","author":"Callen","year":"1989","journal-title":"J Am Acad Dermatol"},{"key":"10.1067\/mjd.2001.112325_bib178","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/0190-9622(95)90218-X","article-title":"Efficacy of human intravenous immune globulin in pyoderma gangrenosum","volume":"32","author":"Gupta","year":"1995","journal-title":"J Am Acad Dermatol"},{"key":"10.1067\/mjd.2001.112325_bib179","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/S0190-9622(98)70052-0","article-title":"Successful treatment of pyoderma gangrenosum with intravenous human immunoglobulin","volume":"39","author":"Dirschka","year":"1998","journal-title":"J Am Acad Dermatol"},{"key":"10.1067\/mjd.2001.112325_bib180","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1007\/s001050051003","article-title":"[Post-traumatic pyoderma gangrenosum: combination therapy with intravenous immunoglobulins and systemic corticosteroids]","volume":"50","author":"Gleichmann","year":"1999","journal-title":"Hautarzt"},{"key":"10.1067\/mjd.2001.112325_bib181","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/S0190-9622(83)80003-6","article-title":"Erythema multiforme: a critical review of characteristics, diagnostic criteria, and causes","volume":"8","author":"Huff","year":"1983","journal-title":"J Am Acad Dermatol"},{"key":"10.1067\/mjd.2001.112325_bib182","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/1523-1747.ep12277397","article-title":"Detection of herpes simplex virus DNA in cutaneous lesions of erythema multiforme","volume":"93","author":"Brice","year":"1989","journal-title":"J Invest Dermatol"},{"key":"10.1067\/mjd.2001.112325_bib183","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1097\/00005792-198905000-00001","article-title":"Recurrent erythema multiforme","volume":"68","author":"Huff","year":"1989","journal-title":"Medicine (Baltimore)"},{"key":"10.1067\/mjd.2001.112325_bib184","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1111\/j.1365-2133.1993.tb00232.x","article-title":"Recurrent erythema multiforme: clinical features and treatment in a large series of patients","volume":"128","author":"Schofield","year":"1993","journal-title":"Br J Dermatol"},{"key":"10.1067\/mjd.2001.112325_bib185","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1056\/NEJM199103073241005","article-title":"Graft-versus-host disease","volume":"324","author":"Ferrara","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1067\/mjd.2001.112325_bib186","first-page":"347","article-title":"[Intravenous immunoglobulins in bone marrow transplantation]","volume":"15","author":"Andolina","year":"1993","journal-title":"Pediatr Med Chir"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962201954155?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962201954155?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T21:23:22Z","timestamp":1759267402000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962201954155"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,6]]},"references-count":186,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2001,6]]}},"alternative-id":["S0190962201954155"],"URL":"https:\/\/doi.org\/10.1067\/mjd.2001.112325","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2001,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"High-dose intravenous immunoglobulins: An approach to treat severe immune-mediated and autoimmune diseases of the skin","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1067\/mjd.2001.112325","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2001 American Academy of Dermatology. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}